Cargando…

Gremlin-1 for the Differential Diagnosis of Idiopathic Pulmonary Fibrosis Versus Other Interstitial Lung Diseases: A Clinical and Pathophysiological Analysis

PURPOSE: The differential diagnosis of interstitial lung diseases (ILDs), particularly idiopathic pulmonary fibrosis (IPF) versus other non-IPF ILDs, is important for selecting the appropriate treatment. This retrospective study aimed to explore the utility of gremlin-1 for the differential diagnosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aoshima, Yoichiro, Enomoto, Yasunori, Muto, Shigeki, Meguro, Shiori, Kawasaki, Hideya, Kosugi, Isao, Fujisawa, Tomoyuki, Enomoto, Noriyuki, Inui, Naoki, Nakamura, Yutaro, Suda, Takafumi, Iwashita, Toshihide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Interstitial Lung Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203516/ https://www.ncbi.nlm.nih.gov/pubmed/33770226 http://dx.doi.org/10.1007/s00408-021-00440-y

Ejemplares similares

LTBP2 is secreted from lung myofibroblasts and is a potential biomarker for idiopathic pulmonary fibrosis
por: Enomoto, Yasunori, et al.
Publicado: (2018)

CD248 and integrin alpha-8 are candidate markers for differentiating lung fibroblast subtypes
por: Matsushima, Sayomi, et al.
Publicado: (2020)

Incidentally discovered mesenteric paraganglia as large as a lymph node in the sigmoid mesocolon, a possible origin of mesenteric paraganglioma
por: Suzuki, Daisuke, et al.
Publicado: (2020)

Accurate deep learning model using semi-supervised learning and Noisy Student for cervical cancer screening in low magnification images
por: Kurita, Yuki, et al.
Publicado: (2023)

Difference in the distribution of tumor‐infiltrating CD8+ T cells and FOXP3+ T cells between micronodular thymoma with lymphoid stroma and micronodular thymic carcinoma with lymphoid stroma
por: Yagi, Haruna, et al.
Publicado: (2021)

Immunohistochemical examination using the pericyte marker myosin 1B in a perivascular myoid tumor of soft tissue with definitive pericytic differentiation
por: Meguro, Shiori, et al.
Publicado: (2019)

An autopsy case of ovarian mucinous cystic tumor complicated by ovarian abscess and a review of the English literature
por: Suzuki, Daisuke, et al.
Publicado: (2022)

An autopsy case of disseminated carcinomatosis of the bone marrow from esophageal adenocarcinoma
por: Suzuki, Daisuke, et al.
Publicado: (2023)

Nasal glomus tumor: A rare nasal tumor with diffuse and strongly positive synaptophysin expression
por: Meguro, Shiori, et al.
Publicado: (2019)

Lung cancer development in patients with connective tissue disease–related interstitial lung disease: A retrospective observational study
por: Enomoto, Yasunori, et al.
Publicado: (2016)

Direct isolation of myofibroblasts and fibroblasts from bleomycin-injured lungs reveals their functional similarities and differences
por: Akamatsu, Taisuke, et al.
Publicado: (2013)

Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA(1)) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD)
por: Corte, Tamera J, et al.
Publicado: (2021)

Utility of radial endobronchial ultrasonography combined with transbronchial lung cryobiopsy in patients with diffuse parenchymal lung diseases: a multicentre prospective study
por: Inomata, Minoru, et al.
Publicado: (2021)

Simple method for detecting idiopathic interstitial pneumonias by measuring vertical lung length on chest X-ray
por: Karayama, Masato, et al.
Publicado: (2021)

The NanoSuit method: a novel histological approach for examining paraffin sections in a nondestructive manner by correlative light and electron microscopy
por: Kawasaki, Hideya, et al.
Publicado: (2019)

Survival and acute exacerbation for patients with idiopathic pulmonary fibrosis (IPF) or non-IPF idiopathic interstitial pneumonias: 5-year follow-up analysis of a prospective multi-institutional patient registry
por: Tsubouchi, Kazuya, et al.
Publicado: (2023)

Paraneoplastic Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Should Be Treated with Low-dose Prednisolone During Pembrolizumab Therapy: The Authors' Reply
por: Karayama, Masato, et al.
Publicado: (2019)

Synchronous Occurrence of Bazex Syndrome and Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome in a Patient with Lung Cancer
por: Aoshima, Yoichiro, et al.
Publicado: (2019)

Severe respiratory failure associated with influenza B virus infection
por: Kato, Shinpei, et al.
Publicado: (2015)

An Autopsy Case of a 5-Year-Old Child with Acute Pancreatitis Caused by Eosinophilic Granulomatosis with Polyangiitis-like Necrotizing Vasculitis
por: Yagi, Haruna, et al.
Publicado: (2019)

Radiologic pleuroparenchymal fibroelastosis-like lesion in connective tissue disease-related interstitial lung disease
por: Enomoto, Yasunori, et al.
Publicado: (2017)

Deficiency of tumour necrosis factor-related apoptosis-inducing ligand exacerbates lung injury and fibrosis
por: McGrath, Emmet E, et al.
Publicado: (2012)

A qualitative study of informal caregivers’ perspectives on the effects of idiopathic pulmonary fibrosis
por: Belkin, Amanda, et al.
Publicado: (2014)

Investigating significant health trends in idiopathic pulmonary fibrosis (INSIGHTS-IPF): rationale, aims and design of a nationwide prospective registry
por: Behr, Juergen, et al.
Publicado: (2014)

Cross-Atlantic modification and validation of the A Tool to Assess Quality of Life in Idiopathic Pulmonary Fibrosis (ATAQ-IPF-cA)
por: Yorke, Janelle, et al.
Publicado: (2014)

Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials
por: Saketkoo, Lesley Ann, et al.
Publicado: (2014)

Combined pulmonary fibrosis and emphysema: effect of pulmonary rehabilitation in comparison with chronic obstructive pulmonary disease
por: Tomioka, Hiromi, et al.
Publicado: (2016)

Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trials
por: Lancaster, Lisa, et al.
Publicado: (2016)

Rationale for and design of the Idiopathic Pulmonary Fibrosis–PRospective Outcomes (IPF-PRO) registry
por: O'Brien, Emily C, et al.
Publicado: (2016)

Sequencing of idiopathic pulmonary fibrosis-related genes reveals independent single gene associations
por: Coghlan, Meghan A, et al.
Publicado: (2014)

Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis
por: Nathan, Steven D, et al.
Publicado: (2016)

Antineutrophil cytoplasmic antibody-positive conversion and microscopic polyangiitis development in patients with idiopathic pulmonary fibrosis
por: Kagiyama, Naho, et al.
Publicado: (2015)

Mindfulness-based stress reduction in patients with interstitial lung diseases: a pilot, single-centre observational study on safety and efficacy
por: Sgalla, Giacomo, et al.
Publicado: (2015)

Lymphangiogenic factors are associated with the severity of hypersensitivity pneumonitis
por: Yamashita, Masahiro, et al.
Publicado: (2015)

Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis
por: Kreuter, Michael, et al.
Publicado: (2017)

Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF
por: Mercer, Paul F, et al.
Publicado: (2016)

Yield of EBUS-TBNA for the diagnosis of sarcoidosis: impact of operator and cytopathologist experience
por: Navasakulpong, Asma, et al.
Publicado: (2016)

Randomised clinical trial of an early palliative care intervention (SUPPORT) for patients with idiopathic pulmonary fibrosis (IPF) and their caregivers: protocol and key design considerations
por: Lindell, Kathleen Oare, et al.
Publicado: (2018)

Dose modification and dose intensity during treatment with pirfenidone: analysis of pooled data from three multinational phase III trials
por: Nathan, Steven D, et al.
Publicado: (2018)

Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebo-controlled INMARK®trial
por: Maher, Toby M, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jrmsk371o8115150pqrgospf9v